Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Hyperinsulinemia is thought to enhance cancer risk. A possible mechanism is induction of oxidative stress and DNA damage by insulin, Here, the effect of a combination of metformin with insulin was investigated in vitro and in vivo. The rationales for this were the reported antioxidative properties of metformin and the aim to gain further insights into the mechanisms responsible for protecting the genome from insulin-mediated oxidative stress and damage. The comet assay, a micronucleus frequency test, and a mammalian gene mutation assay were used to evaluate the DNA damage produced by insulin alone or in combination with metformin. For analysis of antioxidant activity, oxidative stress, and mitochondrial disturbances, the cell-free ferric reducing antioxidant power assay, the superoxide-sensitive dye dihydroethidium, and the mitochondrial membrane potential-sensitive dye 5,5',6,6'tetrachloro-1,1',3,3'-tetraethylbenzimidazol-carbocyanine iodide were applied. Accumulation of p53 and pAKT were analyzed. As an in vivo model, hyperinsulinemic Zucker diabetic fatty rats, additionally exposed to insulin during a hyperinsulinemic-euglycemic clamp, were treated with metformin. In the rat kidney samples, dihydroethidium staining, p53 and pAKT analysis, and quantification of the oxidized DNA base 8-oxo-7,8-dihydro-2'-deoxyguanosine were performed. Metformin did not show intrinsic antioxidant activity in the cell-free assay, but protected cultured cells from insulin-mediated oxidative stress, DNA damage, and mutation. Treatment of the rats with metformin protected their kidneys from oxidative stress and genomic damage induced by hyperinsulinemia. Metformin may protect patients from genomic damage induced by elevated insulin levels. This may support efforts to reduce the elevated cancer risk that is associated with hyperinsulinemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The genotoxicity-protective effects of metformin are demonstrated in human lymphocytes, normal and diabetic rats, rat and mouse bone marrow cells, mouse kidney cells as evidenced by a reduction in micronuclei and chromosomal aberrations”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Othman et al. 2016
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Benzie, I. F. F., & Strain, J. J. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)99005-5 · Cited by 3,929 · cited 1×
“Total antioxidant activity was measured according to (29).”
MethodMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 1×
“Metformin is known to inhibit complex I of the mitochondrial respiratory chain I (15, 44).”
BackgroundMetformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,349 · cited 2×
“Metformin is known to inhibit complex I of the mitochondrial respiratory chain I (15, 44).”
BackgroundVigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009
Role of oxidative stress and DNA damage in human carcinogenesis
Kryston, T. B., Georgiev, A. B., Pissis, P., & Georgakilas, A. G. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2010.12.016 · Cited by 930 · cited 2×
“As reviewed by Kryston et al (28), oxidative DNA damage is mutagenic and can lead to cancer induction.”
BackgroundAntidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S., Rohan, T. E., Manson, J. E., Li, J., Ho, G. Y. F., Xue, X., Anderson, G. L., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn415 · Cited by 563
Metabolic syndrome, hyperinsulinemia, and colon cancer: a review
Giovannucci, E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.836s · Cited by 531
Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
Ben Sahra, I., Le Marchand-Brustel, Y., Tanti, J.-F., & Bost, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1186 · Cited by 493 · cited 1×
“and prostate cancer cells were reported recently (22, 23).”
BackgroundAkt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart
Kovacic, S., Soltys, C.-L. M., Barr, A. J., Shiojima, I., Walsh, K., & Dyck, J. R. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305371200 · Cited by 406
Metformin reduces endogenous reactive oxygen species and associated DNA damage
Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0536 · Cited by 372 · cited 2×
“A similar suggestion was published by Algire and colleagues (39, 41) who reported that metformin attenuated paraquat-mediated elevation in ROS production and related DNA damage, but had no effect on similar alterations induced by H2O2.”
BackgroundBao, B., Wang, Z., Ali, S., Ahmad, A., Azmi, A. S., Sarkar, S. H., Banerjee, S., Kong, D., Li, Y., Thakur, S., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0299 · Cited by 337 · cited 1×
“ies (49, 50) suggested the antiproliferative effect of met-”
BackgroundDoes diabetes therapy influence the risk of cancer?
Smith, U., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1441-5 · Cited by 316
AMPK as a mediator of hormonal signalling
Lim, C. T., Kola, B., & Korbonits, M. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0063 · Cited by 298
on behalf of the Diabetes and Cancer Research Consortium, Johnson, J. A., Carstensen, B., Witte, D., Bowker, S. L., Lipscombe, L., & Renehan, A. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2525-1 · Cited by 260
Avilés-Santa, L., Sinding, J., & Raskin, P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00004 · Cited by 225
Zakikhani, M., Blouin, M.-J., Piura, E., & Pollak, M. N. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0763-9 · Cited by 213 · cited 1×
“Another research group also reported effects of metformin on AKT-activation, although not in the context of DNA damage, but supporting our findings (45).”
ResultEsteghamati, A., Eskandari, D., Mirmiranpour, H., Noshad, S., Mousavizadeh, M., Hedayati, M., & Nakhjavani, M. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.006 · Cited by 212 · cited 1×
“It was found that metformin can have an effect on oxidative stress markers (24, 25).”
BackgroundDiabetes, cancer, and metformin: connections of metabolism and cell proliferation
Gallagher, E. J., & LeRoith, D. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06285.x · Cited by 202 · cited 1×
“ies (49, 50) suggested the antiproliferative effect of met-”
BackgroundBoyd, D. B. (2003) · Integrative Cancer Therapies · doi:10.1177/1534735403259152 · Cited by 182
Combination of Insulin and Metformin in the Treatment of Type 2 Diabetes
Wulffelé, M. G., Kooy, A., Lehert, P., Bets, D., Ogterop, J. C., Borger van der Burg, B., Donker, A. J. M., & Stehouwer, C. D. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2133 · Cited by 175
Giugliano, D., Quatraro, A., Consoli, G., Minei, A., Ceriello, A., De Rosa, N., & D'Onofrio, F. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315466 · Cited by 169 · cited 1×
“Studies reported that in type 2 diabetic patients who are treated with insulin, the combination of insulin and metformin resulted in superior glycemic control compared with that for insulin therapy alone,withdecreases in insulinrequirementsandweightgain (16).”
BackgroundMetabolic syndrome, hyperinsulinemia, and cancer
Hsu, I. R., Kim, S. P., Kabir, M., & Bergman, R. N. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.867s · Cited by 158
Metformin induces suppression of NAD(P)H oxidase activity in podocytes
Piwkowska, A., Rogacka, D., Jankowski, M., Dominiczak, M. H., Stępiński, J., & Angielski, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.119 · Cited by 150 · cited 2×
“This is in agreement with Piwkowska et al who showed that metformin can suppress the NADPH oxidase activity in podocytes leading to suppression of ROS production (38).”
BackgroundResultThe kinetics of insulin in man. II. Role of the liver
Ferrannini, E., & Cobelli, C. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030202 · Cited by 129 · cited 1×
“At later stages, the pancreas can often not produce sufficient amounts of insulin any more, and patients require exogenous insulin as a treatment, again exposing them to higher than normal insulin levels (12, 14).”
BackgroundInsulin Resistance, Apoptosis, and Colorectal Adenoma Risk
Keku, T. O., Lund, P. K., Galanko, J. A., Simmons, J. G., Woosley, J. T., & Sandler, R. S. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0239 · Cited by 128 · cited 1×
“activity (51, 52) and some reported that metformin can act”
BackgroundBalkau, B., Kahn, H. S., Courbon, D., Eschwège, E., & Ducimetière, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.843 · Cited by 101
Type 2 Diabetes and Cancer: What Is the Connection?
Cannata, D., Fierz, Y., Vijayakumar, A., & LeRoith, D. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20167 · Cited by 91 · cited 1×
“Hyperinsulinemia, an elevated insulin blood level characteristic of certain stages of diabetes, was investigated as possible reason for cancer development (11, 35).”
BackgroundFaure, P., Wiernsperger, N., Polge, C., Favier, A., & Halimi, S. (2008) · Clinical Science · doi:10.1042/cs20070276 · Cited by 85 · cited 1×
“It was found that metformin can have an effect on oxidative stress markers (24, 25).”
BackgroundChao, M., Yen, C., & Hu, C. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.10.003 · Cited by 71 · cited 3×
“100 L of DNA samples were loaded on the trap column using an auto sampler (Agilent 1100 series) and the content of 8-oxodG was quantified as reported elsewhere (31, 32).”
MethodAntidiabetic Drug Metformin Induces Apoptosis in Human MCF Breast Cancer via Targeting ERK Signaling
Malki, A. M., & Youssef, A. (2011) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504011x13021877989838 · Cited by 69 · cited 1×
“as apoptosis inducer in cancer cells (53, 54), which could”
BackgroundDiabetes and Risk of Renal Cell Carcinoma
Habib, S. L., Prihoda, T. J., Luna, M., & Werner, S. A. (2012) · Journal of Cancer · doi:10.7150/jca.3718 · Cited by 66 · cited 1×
“Cancer represents 13% of this mortality rate (33).”
BackgroundJohnson, J. A., & Gale, E. A. M. (2010) · Diabetes · doi:10.2337/db10-0334 · Cited by 64
Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro
Othman, E. M., Leyh, A., & Stopper, H. (2013) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2013.03.006 · Cited by 57 · cited 1×
“In previous studies (26, 36) we showed the ability of”
BackgroundSelf-citationChong, C. R., & Chabner, B. A. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0286 · Cited by 47
Brink, A., Lutz, U., Völkel, W., & Lutz, W. K. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.10.046 · Cited by 46 · cited 2×
“100 L of DNA samples were loaded on the trap column using an auto sampler (Agilent 1100 series) and the content of 8-oxodG was quantified as reported elsewhere (31, 32).”
MethodKumar, A., Al-Sammarraie, N., DiPette, D. J., & Singh, U. S. (2014) · Oncotarget · doi:10.18632/oncotarget.2606 · Cited by 41 · cited 1×
“as apoptosis inducer in cancer cells (53, 54), which could”
BackgroundHyperinsulinemia in colon, stomach and breast cancer patients
Yam, D., Fink, A., Mashiah, A., & Ben-Hur, E. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04211-5 · Cited by 39
Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
Pulito, C., Sanli, T., Rana, P., Muti, P. C., Blandino, G., & Strano, S. (2013) · Metabolites · doi:10.3390/metabo3041051 · Cited by 33 · cited 1×
“and prostate cancer cells were reported recently (22, 23).”
BackgroundOthman, E. M., Kreissl, M. C., Kaiser, F. R., Arias-Loza, P.-A., & Stopper, H. (2013) · Endocrinology · doi:10.1210/en.2012-1768 · Cited by 32 · cited 19×
“Metformin opposed the effect of insulin on mitochondria and on AKT activation During previous studies, we reported some steps in the signaling pathway by which insulin can stimulate ROS production and mediate DNA damage.”
BackgroundSelf-citationOnaran, İ., Güven, G. S., Özdaş, Ş., Kanıgür, G., & Vehid, S. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.06.036 · Cited by 32 · cited 1×
“In agreement with this, Kanigür-Sultuybek et al (42, 43) observed that metformin could not protect lymphocytes in vitro from cumene hydroperoxide-induced oxidative stress-mediated DNA damage.”
ResultSignaling steps in the induction of genomic damage by insulin in colon and kidney cells
Othman, E. M., Hintzsche, H., & Stopper, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.010 · Cited by 31 · cited 2×
“The reduced AKT-activation that we found points to an involvement of the PI3-K/AKT pathway, which we showed to be activated by insulin (37).”
BackgroundSelf-citationZamami, Y., Takatori, S., Hobara, N., Yabumae, N., Tangsucharit, P., Jin, X. K., Hashikawa, N., Kitamura, Y., Sasaki, K., & Kawasaki, H. (2011) · Hypertension Research · doi:10.1038/hr.2011.97 · Cited by 29
Numata, T., Araya, J., Fujii, S., Hara, H., Takasaka, N., Kojima, J., Minagawa, S., Yumino, Y., Kawaishi, M., Hirano, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1004218 · Cited by 28 · cited 1×
“activity (51, 52) and some reported that metformin can act”
BackgroundNo increased chromosomal damage in l-DOPA-treated patients with Parkinson’s disease: a pilot study
Oli, R. G., Fazeli, G., Kuhn, W., Walitza, S., Gerlach, M., & Stopper, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0401-z · Cited by 25 · cited 1×
“The genomic DNA was isolated from the rat kidney tissue according to a published protocol (30).”
MethodSelf-citationKanigür-Sultuybek, Ozdas, Curgunlu, Tezcan, & Onaran (2007) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.2007.18.2.129 · Cited by 21 · cited 1×
“In agreement with this, Kanigür-Sultuybek et al (42, 43) observed that metformin could not protect lymphocytes in vitro from cumene hydroperoxide-induced oxidative stress-mediated DNA damage.”
ResultPrevention of Mutagenesis: New Potential Mechanisms of Metformin Action in Neoplastic Cells
Bost, F., Ben‐Sahra, I., & Tanti, J. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0085 · Cited by 16 · cited 1×
“A similar suggestion was published by Algire and colleagues (39, 41) who reported that metformin attenuated paraquat-mediated elevation in ROS production and related DNA damage, but had no effect on similar alterations induced by H2O2.”
da Silva, B. S., Rovaris, D. L., Bonotto, R. M., Meyer, J. B. F., Grohe, R. E., Perassolo, M. S., Palazzo, R. P., Maluf, S. W., Linden, R., & de Andrade, F. M. (2013) · Mutagenesis · doi:10.1093/mutage/get029 · Cited by 16 · cited 2×
“At the pharmacological concentrations applied, metformin also reduced the genotoxicity and mutagenicity induced by insulin. da Silva et al (39) reported an inverse correlation of the metformin plasma concentration with the micronucleus frequency in peripheral human lymphocytes.”
BackgroundThe Role of Insulin Resistance and Hyperinsulinemia in Cancer Causation
Giovannucci, E. L. (2005) · Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents · doi:10.2174/1568013053005517 · Cited by 9 · cited 1×
“Hyperinsulinemia, an elevated insulin blood level characteristic of certain stages of diabetes, was investigated as a possible reason for cancer development (11, 35).”
Background
Cited by
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
“…are demonstrated in human lymphocytes, normal and diabetic rats, rat and mouse bone marrow cells, mouse kidney cells as evidenced by a reduction in micronuclei and chromosomal aberrations (Sant’Anna et al. 2013, Cheki et al. 2016, Othman et al. 2016, Najafi et al. 2018, Cheki et al. 2019).”
BackgroundMetformin: prevention of genomic instability and cancer: a review
Najafi, M., Cheki, M., Rezapoor, S., Geraily, G., Motevaseli, E., Carnovale, C., Clementi, E., & Shirazi, A. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.01.007 · Cited by 75
Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease
Cheng, F., Liu, Y.-L., Du, J., & Lin, J. (2022) · Aging and Disease · doi:10.14336/ad.2021.1213 · Cited by 87
Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes
Dogan Turacli, I., Candar, T., Yuksel, E. B., Kalay, S., Oguz, A. K., & Demirtas, S. (2018) · Biochimie · doi:10.1016/j.biochi.2018.08.002 · Cited by 46
Direct toxicity of insulin on the human placenta and protection by metformin
Vega, M., Mauro, M., & Williams, Z. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.032 · Cited by 41
Metadata
- Authors
- Othman, E. M., Oli, R. G., Arias-Loza, P.-A., Kreissl, M. C., & Stopper, H.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Stopper, Helga
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2015-12-04
- Volume
- 157
- Issue
- 2
- Pages
- 548-559
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2186665901
- Cited by
- 23
- References
- 53
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 4
- FWCI
- 0.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- metformin, insulin, hyperinsulinemia, DNA damage, oxidative stress, genotoxicity, kidney, Zucker diabetic fatty rats, p53, Akt, 8-oxo-7,8-dihydro-2'-deoxyguanosine, cancer risk, mitochondrial membrane potential, antioxidant activity
- MeSH terms
- Animals, Antioxidants, Cells, Cultured, Diabetes Mellitus, Experimental, DNA Damage, Hyperinsulinism, Hypoglycemic Agents, Insulin, Kidney, Male, Metformin, Neoplasms, Rats, Zucker, Reactive Oxygen Species, Oxidative Stress, Cytoprotection, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.